glp-1 and breast cancer Frontiers GLP-1 use linked to lower

Important update for our community The White House recently announced that TrumpRX will be lowering the cost of brand-name Ozempic and Wegovy to $350/month

GLP-1 receptor agonists have shown cardiovascular benefits beyond weight loss, including potential improvements in cholesterol profiles

Looking Ahead As the market evolves, stakeholders are watching for regulatory updates and court decisions that could reshape the boundaries of compounding

These blockbuster medications have been associated with a range of health benefits, but a lack of data about how the drugs impact adults age 65 and up has clini

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

In this narrative review we introduce the preclinical data related to this receptor pathway and pancreatic ductal adenocarcinoma